EMA Authorised: MenQuadfi (Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency authorised MenQuadfi, a tetravalent meningococcal conjugate vaccine (serogroups A, C, W-135 and Y) manufactured by Sanofi Winthrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenQuadfi (Meningococcal quadrivalent conjugate vaccine)

Snippet

Status: Authorised. Therapeutic area: Meningitis, Meningococcal. MAH: Sanofi Winthrop Industrie. Decision date: 24/03/2026